• SASL is an interdisciplinary group of Swiss scientists, clinicians and translational researchers interested in liver biology and disease. Our mission is to promote research, to disseminate knowledge and to prevent and cure liver disease.

  • Corona Virus Pandemic:
    recommendations for patients with liver diseases

  • Corona Virus Pandemie:
    Empfehlungen für Patienten mit Lebererkrankungen

  • Pandémie de SRAS-CoV-2:
    Recommandations pour les patients atteints d'une maladie du foie

  • Pandemia Coronavirus:
    Raccomandazioni per i pazienti con malattie del fegato

  • New regulations for financial support of SASL studies

  • Download the free SASL HCV Advisor app for your smartphone

SASL School of Hepatology

Upcoming Courses:
SASL School Number 28

Monday, 15 Jun 2020, 1730h-1900h
SASL hepatology news. David Semela, St. Gallen
COVID-19 and the liver. Thomas Berg, Leipzig
Management of polycystic liver disease. Joost Drenth , Nijmegen

SASL School Number 29

Monday, 14 Sep 2020, 1730h-1900h
SASL hepatology news. ,
HBV and HCV update 2020. ,
Hepatocellular carcinoma: Systemic treatment options. ,

SASL School Number 30

Monday, 14 Dec 2020, 1730h-1900h
SASL hepatology news. ,
NASH/NAFLD: Current and future treatment. ,
Portal hypertension: Baveno VII news . ,

Calculators

MELD score

Calculates the Model of Endstage Liver Disease Score

Alcoholic hepatitis score calculator

Set of calculators for alcoholic hepatitis

Lille model

A tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids

Post-operative Mortality Risk Calculator

Mayo Clinic Model for calculation of post-operative mortality in patients with liver cirrhosis

CIOMS/RUCAM

Causality assessment of adverse reactions to drugs

HOMA

Homeostasis model assessment of insulin resistance

more calculators

Upcoming Congresses

Member Payment

Account
SASL Zürich
PostFinance: 30-8596-4
IBAN: CH85 09000000 300085964